PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF HALOFANTRINE AND ITS MAIN METABOLITE IN MALARIA PATIENTS

被引:20
作者
GIMENEZ, F
GILLOTIN, C
BASCO, LK
BOUCHAUD, O
AUBRY, AF
WAINER, IW
LEBRAS, J
FARINOTTI, R
机构
[1] FAC PHARM CHATENAY MALABRY,DEPT CLIN PHARM,CHATENAY MALABRY,FRANCE
[2] HOP BICHAT CLAUDE BERNARD,SERV PARASITOL,PARIS,FRANCE
[3] HOP BICHAT CLAUDE BERNARD,DEPT MALAD INFECT & TROP,PARIS,FRANCE
[4] MCGILL UNIV,DIV ONCOL,MONTREAL,PQ,CANADA
关键词
HALOFANTRINE; ENANTIOMERS; MALARIA; STEREOSELECTIVITY; PLASMODIUM FALCIPARUM;
D O I
10.1007/BF00196116
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The plasma concentrations of the enantiomers of halofantrine and its N-desbutyl metabolite in six patients with malaria were measured after oral administration of 3 x 750 mg doses of micronised, racemic halofantrine hydrochloride given at 6-hour intervals. Significant differences were observed between the plasma concentrations of the enantiomers both of halofantrine and its N-monodesbutyl metabolite. AUC(0)84h values were higher for (+)halofantrine (9917 mu g.ml(-1).h) than for (-)-halofantrine (6127 mu g.ml(-1).h). The clinical significance of these observations is not known. The isomers have equipotent activity in vitro but their relative toxicity has not yet been assessed.
引用
收藏
页码:561 / 562
页数:2
相关论文
共 6 条
[1]   INVITRO ACTIVITY OF THE ENANTIOMERS OF MEFLOQUINE, HALOFANTRINE AND ENPIROLINE AGAINST PLASMODIUM-FALCIPARUM [J].
BASCO, LK ;
GILLOTIN, C ;
GIMENEZ, F ;
FARINOTTI, R ;
LEBRAS, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (05) :517-520
[2]   ANTIMALARIAL ACTIVITY INVITRO OF THE N-DESBUTYL DERIVATIVE OF HALOFANTRINE [J].
BASCO, LK ;
GILLOTIN, C ;
GIMENEZ, F ;
FARINOTTI, R ;
LEBRAS, J .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (01) :12-13
[3]  
BROOM C, 1989, HALOFANTRINE TREATME, P15
[4]   THE DETERMINATION OF THE ENANTIOMERS OF HALOFANTRINE AND MONODESBUTYLHALOFANTRINE IN PLASMA AND WHOLE-BLOOD USING SEQUENTIAL ACHIRAL CHIRAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
GIMENEZ, F ;
AUBRY, AF ;
FARINOTTI, R ;
KIRKLAND, K ;
WAINER, IW .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1992, 10 (2-3) :245-250
[5]   CARDIAC EFFECT OF HALOFANTRINE [J].
KARBWANG, J ;
BANGCHANG, KN ;
BUNNAG, D ;
HARINASUTA, T ;
LAOTHAVORN, P .
LANCET, 1993, 342 (8869) :501-501
[6]  
KARBWANG J, 1991, BR J CLIN PHARM, V32, P39